Even before the current pandemic laser-focused the pharmaceutical industry’s attention on achieving a coronavirus vaccine, the spotlight on injectable drugs was bright thanks to the accelerating innovation in delivery devices and the rise of chronic diseases. According to ReportLinker’s report “Injectable Drug Delivery Devices Market - Growth, Trends, and Forecast”, the growing prevalence of conditions like cardiovascular diseases, obesity, and diabetes drove significant growth in the injectable device market as of February 2020.1 Naturally, more pharmaceutical companies are producing injectable drug delivery devices to meet the growing need. Additionally, innovation in injectable devices have contributed to advantages such as enhanced convenience and reduced patient pain during injections—all of which makes injectables a safer and better experience for both patients and administrators. Still, producing injectable devices does not come without challenges. To minimize risk, here are five considerations that drug manufacturers and packaging designers should make.